Skip to main content

Texas A&M Wins $12.3M Defense Contract

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute for Genomic Medicine (TIGM) at Texas A&M University said today that it has won a contract totaling $12.3 million from the US Department of Defense to screen potential targets that can be used to combat biothreats such as viral and bacterial pathogens and toxins.

The funding from the Defense Threat Reduction Agency (DTRA) will be used to develop high-throughput screening measures in mouse stem cells to discover new vaccines and therapies to counter serious biothreats.

Researchers at TIGM plan to screen over 3,500 different genes to find those that enable microbes and toxins to harm cells and tissues. When those candidates are identified, TIGM will use those to develop therapies to be tested in tissues and pre-clinical models, the university said.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.